WASHINGTON, United States (AFP) — US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. Paul Schaper, the company’s executive director of global public policy, told AFP that Merck, known as MSD outside the US and Canada, began working on its access strategy from July 2020, long before the efficacy […]